Lecanemab: European drug agency rejects Alzheimer’s drug amid debate over efficacy and safety
Reference2 articles.
1. European Medicines Agency. Leqembi. 25 Jul 2024. https://www.ema.europa.eu/en/medicines/human/EPAR/leqembi
2. Alzheimer’s disease: Lecanemab gets full FDA approval and black box safety warning
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献